IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Polaris Venture Management Co. V, L.L.C.

Q1 2021 Holdings

Filed 2021-05-12 | 8 holdings | $77.1K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Fate Therapeutics, Inc.(FATE)Common Stock31189P102$47.0K569,88960.9%
Lyra Therapeutics, Inc.(LYRA)Common Stock55234L105$12.8K1,100,85216.5%
Selecta Biosciences, Inc.(SELBUSD)Common Stock816212104$12.6K2,773,47916.3%
x4 Pharmaceuticals Inc.(ASNSUSD)Common Stock98420X103$2.7K311,4923.5%
Atyr Pharma Inc.(LIFEUSD)Common Stock002120103$581130,5720.8%
Dare Bioscience, Inc.(CERUEUR)Common Stock23666P101$551326,2410.7%
Genocea Biosciences, Inc.(GNCAQ)Common Stock372427401$535197,3450.7%
Pulmatrix, Inc.Common Stock74584P202$478359,4410.6%